自体冷冻保存卵巢组织移植后妊娠的围产期结局:系统综述与合并分析
本系统综述合并分析了58项观察性研究,共122名女性在自体冷冻保存卵巢组织移植后获得162次分娩(154例单胎、8例双胎),产出170名新生儿。子痫前期发生率为9.4%,高于一般妊娠人群;未接受化疗和自然受孕与较低的围产期并发症率相关。基于低确定性证据,除子痫前期外,围产期并发症率未较一般妊娠人群升高。
要点
- 162次分娩中66.7%为自然受孕,33.3%通过辅助生殖技术受孕。
- 子痫前期发生率9.4%,妊娠期高血压7.6%,HELLP综合征1.9%。
- 冻存前未接受化疗(OR 0.23)和自然受孕(OR 0.29)与较低围产期并发症率相关。
核心结论
- 基于观察性研究的低确定性证据,自体冷冻保存卵巢组织移植后妊娠的围产期并发症率除子痫前期外未较一般妊娠人群升高。
- 子痫前期发生率升高可能与化疗暴露、基础疾病及辅助生殖技术的普遍使用有关。
- 需要进一步开展更大规模研究探讨自体冷冻保存卵巢组织移植妊娠中子痫前期发生率升高的原因。
研究设计与样本
- 系统综述与合并分析,检索MEDLINE、Embase和Cochrane Library数据库从建库至2023年10月22日的文献。
- 纳入报告自体冷冻保存卵巢组织移植后活产的观察性研究(队列研究、病例系列和病例报告),共纳入58项研究。
- 纳入122名女性,共162次分娩(154例单胎和8例双胎),产出170名新生儿。
- 两名评价者独立进行研究选择、数据提取和偏倚风险评估,遵循PRISMA指南,方案注册于PROSPERO(CRD42023469296)。
主要发现
- 83.6%的女性患有恶性疾病,51.0%的女性在卵巢组织冷冻保存前接受过某种形式的化疗。
- 162次分娩中108次(66.7%)为自然受孕,54次(33.3%)通过辅助生殖技术受孕。
- 88.5%的新生儿出生体重适于胎龄,8.3%为小于胎龄儿,3.1%为大于胎龄儿;早产率为9.4%。
- 妊娠期高血压疾病发生率为18.9%,其中妊娠期高血压7.6%、子痫前期9.4%、HELLP综合征1.9%;妊娠期糖尿病和早产胎膜早破发生率均为3.8%。
- 3名移植受者的4名新生儿报告了新生儿异常:关节挛缩、先天性白内障及双胎之一膈疝。
局限性
- 基于观察性研究的低确定性证据。
- 需要进一步开展更大规模研究探讨子痫前期发生率升高的原因。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: This study aimed to synthesize the existing evidence on perinatal outcomes after autologous cryopreserved ovarian tissue transplantation, concurrently identifying key factors influencing these outcomes. DATA SOURCES: A comprehensive search was performed on MEDLINE, Embase, and Cochrane Library databases to identify relevant studies on the effect of autologous cryopreserved ovarian tissue transplantation on perinatal outcomes from inception to October 22, 2023. Where there was missing information, the authors were contacted for updated data. STUDY ELIGIBILITY CRITERIA: Observational studies, such as cohort studies, case series, and case reports that reported a live birth after autologous cryopreserved ovarian tissue transplantation, were considered eligible. Studies lacking data on women's demographic characteristics, autologous cryopreserved ovarian tissue transplantation procedure details, or perinatal outcomes were excluded. In addition, cases involving fresh or nonautologous transplantations and those addressing primary ovarian insufficiency were excluded. METHODS: Two reviewers (M.E. and E.U.) independently performed the study selection, data extraction, and risk of bias assessment, and the results were then reviewed together. The PRISMA guidelines were followed, and the protocol was registered on PROSPERO (CRD42023469296). RESULTS: This review included 58 studies composed of 122 women with 162 deliveries (154 singletons and 8 twins) after autologous cryopreserved ovarian tissue transplantation, resulting in 170 newborns. Of note, 83.6% of the women had a malignant disease. Moreover, most of these women (51.0%) were exposed to some form of chemotherapy before ovarian tissue cryopreservation. Of the 162 childbirths, 108 (66.7%) were conceived naturally, and 54 (33.3%) were conceived through assisted reproductive techniques. The birthweight of 88.5% of newborns was appropriate for gestational age, whereas 8.3% and 3.1% were small for gestational age and large for gestational age, respectively. The preterm birth rate was 9.4%, with the remaining being term deliveries. Hypertensive disorders of pregnancy were noted in 18.9% of women, including pregnancy-induced hypertension in 7.6%, preeclampsia in 9.4%, and hemolysis, elevated liver enzymes, and low platelet count in 1.9%. The incidences of gestational diabetes mellitus and preterm premature rupture of membranes were 3.8% for each condition. Neonatal anomalies were reported in 3 transplant recipients with 4 newborns: arthrogryposis, congenital cataract, and diaphragmatic hernia in a twin. Finally, among the recipients' characteristics, not receiving chemotherapy before ovarian tissue cryopreservation (odds ratio, 0.23; 95% confidence interval, 0.07-0.72; P=.012) and natural conception (odds ratio, 0.29; 95% confidence interval, 0.09-0.92; P=.035) were associated with a lower perinatal complication rate. CONCLUSION: On the basis of low certainty evidence from observational studies, perinatal complication rates did not increase after autologous cryopreserved ovarian tissue transplantation compared with the general pregnant population, except for preeclampsia. This could be due to chemotherapy exposure, underlying medical conditions, and the common use of assisted reproductive techniques. Further larger studies are needed to explore the causes of increased preeclampsia incidence in autologous cryopreserved ovarian tissue transplantation pregnancies.
引用
- Erden M, Uyanik E, Demeestere I, et al. Perinatal outcomes of pregnancies following autologous cryopreserved ovarian tissue transplantation: a systematic review with pooled analysis. Am J Obstet Gynecol. 2024. PMID: 38621483. doi:10.1016/j.ajog.2024.04.012
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。